Malone DC - Search Results

1

Consensus recommendations for systematic evaluation of drug-drug interaction evidence for clinical decision support.

Scheife RT, Hines LE, Boyce RD, Chung SP, Momper JD, Sommer CD, Abernethy DR, Horn JR, Sklar SJ, Wong SK, Jones G, Brown ML, Grizzle AJ, Comes S, Wilkins TL, Borst C, Wittie MA, Malone DC. Scheife RT, et al. Among authors: malone dc. Drug Saf. 2015 Feb;38(2):197-206. doi: 10.1007/s40264-014-0262-8. Drug Saf. 2015. PMID: 25556085 Free PMC article.

2

Concordance of severity ratings provided in four drug interaction compendia.

Abarca J, Malone DC, Armstrong EP, Grizzle AJ, Hansten PD, Van Bergen RC, Lipton RB. Abarca J, et al. Among authors: malone dc. J Am Pharm Assoc (2003). 2004 Mar-Apr;44(2):136-41. doi: 10.1331/154434504773062582. J Am Pharm Assoc (2003). 2004. PMID: 15098847

3

Identification of serious drug-drug interactions: results of the partnership to prevent drug-drug interactions.

Malone DC, Abarca J, Hansten PD, Grizzle AJ, Armstrong EP, Van Bergen RC, Duncan-Edgar BS, Solomon SL, Lipton RB. Malone DC, et al. J Am Pharm Assoc (2003). 2004 Mar-Apr;44(2):142-51. doi: 10.1331/154434504773062591. J Am Pharm Assoc (2003). 2004. PMID: 15098848

4

Community pharmacy managers' perception of computerized drug-drug interaction alerts.

Abarca J, Malone DC, Skrepnek GH, Rehfeld RA, Murphy JE, Grizzle AJ, Armstrong EP, Woosley RL. Abarca J, et al. Among authors: malone dc. J Am Pharm Assoc (2003). 2006 Mar-Apr;46(2):148-53. doi: 10.1331/154434506776180676. J Am Pharm Assoc (2003). 2006. PMID: 16602224

5

Pharmacist workload and pharmacy characteristics associated with the dispensing of potentially clinically important drug-drug interactions.

Malone DC, Abarca J, Skrepnek GH, Murphy JE, Armstrong EP, Grizzle AJ, Rehfeld RA, Woosley RL. Malone DC, et al. Med Care. 2007 May;45(5):456-62. doi: 10.1097/01.mlr.0000257839.83765.07. Med Care. 2007. PMID: 17446832

6

Potential drug-drug interactions within Veterans Affairs medical centers.

Mahmood M, Malone DC, Skrepnek GH, Abarca J, Armstrong EP, Murphy JE, Grizzle AJ, Ko Y, Woosley RL. Mahmood M, et al. Among authors: malone dc. Am J Health Syst Pharm. 2007 Jul 15;64(14):1500-5. doi: 10.2146/ajhp060548. Am J Health Syst Pharm. 2007. PMID: 17617500

7

Reasons provided by prescribers when overriding drug-drug interaction alerts.

Grizzle AJ, Mahmood MH, Ko Y, Murphy JE, Armstrong EP, Skrepnek GH, Jones WN, Schepers GP, Nichol WP, Houranieh A, Dare DC, Hoey CT, Malone DC. Grizzle AJ, et al. Among authors: malone dc. Am J Manag Care. 2007 Oct;13(10):573-8. Am J Manag Care. 2007. PMID: 17927462 Free article.

8

Potential determinants of prescribers' drug-drug interaction knowledge.

Ko Y, Malone DC, D'Agostino JV, Skrepnek GH, Armstrong EP, Brown M, Woosley RL. Ko Y, et al. Among authors: malone dc. Res Social Adm Pharm. 2008 Dec;4(4):355-66. doi: 10.1016/j.sapharm.2007.10.004. Epub 2008 Aug 8. Res Social Adm Pharm. 2008. PMID: 19064242

9

Development of computerized alerts with management strategies for 25 serious drug-drug interactions.

Murphy JE, Malone DC, Olson BM, Grizzle AJ, Armstrong EP, Skrepnek GH. Murphy JE, et al. Among authors: malone dc. Am J Health Syst Pharm. 2009 Jan 1;66(1):38-44. doi: 10.2146/ajhp070046. Am J Health Syst Pharm. 2009. PMID: 19106343

10

Warfarin interactions with substances listed in drug information compendia and in the FDA-approved label for warfarin sodium.

Anthony M, Romero K, Malone DC, Hines LE, Higgins L, Woosley RL. Anthony M, et al. Among authors: malone dc. Clin Pharmacol Ther. 2009 Oct;86(4):425-9. doi: 10.1038/clpt.2009.95. Epub 2009 Jul 8. Clin Pharmacol Ther. 2009. PMID: 19587643

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

274 results

Search Page